Ocugen, Inc. (OCGN)
1.025
0.00 (0.00%)
USD |
NASDAQ |
Sep 11, 16:00
1.04
+0.02
(+1.46%)
After-Hours: 16:29
Ocugen Gross Profit (TTM) : 2.647M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.647M |
| March 31, 2026 | 2.191M |
| December 31, 2025 | 1.82M |
| September 30, 2025 | 1.986M |
| June 30, 2025 | 1.707M |
| March 31, 2025 | 1.824M |
| December 31, 2024 | 2.087M |
| September 30, 2024 | 3.151M |
| June 30, 2024 | 6.15M |
| March 31, 2024 | 5.898M |
| December 31, 2023 | 5.332M |
| September 30, 2023 | 4.808M |
| June 30, 2023 | 1.016M |
| March 31, 2023 | 0.46M |
| December 31, 2022 | -0.064M |
| September 30, 2022 | -1.008M |
| June 30, 2022 | -0.862M |
| March 31, 2022 | -0.732M |
| December 31, 2021 | -0.521M |
| September 30, 2021 | -0.3275M |
| June 30, 2021 | -0.2234M |
| March 31, 2021 | -0.1083M |
| December 31, 2020 | -0.0826M |
| September 30, 2020 | -0.0641M |
| June 30, 2020 | -0.0443M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.0489M |
| December 31, 2019 | -0.0452M |
| September 30, 2019 | -0.0338M |
| June 30, 2019 | -0.0338M |
| March 31, 2019 | -0.2292M |
| December 31, 2018 | -0.3866M |
| September 30, 2018 | -0.728M |
| June 30, 2018 | -1.117M |
| March 31, 2018 | -1.317M |
| December 31, 2017 | -1.539M |
| September 30, 2017 | -1.589M |
| June 30, 2017 | -1.605M |
| March 31, 2017 | -1.637M |
| December 31, 2016 | -1.673M |
| September 30, 2016 | -1.699M |
| June 30, 2016 | -1.708M |
| March 31, 2016 | -1.673M |
| December 31, 2015 | -1.614M |
| September 30, 2015 | -1.426M |
| June 30, 2015 | -1.181M |
| March 31, 2015 | -0.944M |
| December 31, 2014 | -0.726M |
| September 30, 2014 | -0.628M |
| June 30, 2014 | -0.635M |
| March 31, 2014 | -0.592M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.038B |
| Anika Therapeutics, Inc. | 75.00M |
| Gilead Sciences, Inc. | 24.33B |
| MannKind Corp. | 284.03M |
| Vertex Pharmaceuticals, Inc. | 10.94B |